Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Seractil
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Seractil 300mg tablets (Gebro Pharma GmbH)
1001010AMBBACAA
|
Seractil | Dexibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Seractil 300mg tablets (Thornton & Ross)
1001010AMBBAAAA
|
Seractil | Dexibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Seractil 400mg tablets
1001010AMBBABAB
|
Seractil | Dexibuprofen | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.